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Abstract
Although it is well accepted that the constituents of the cellular microenvironment modulate a myriad of cellular processes,
including cell morphology, cytoskeletal dynamics and uptake pathways, the underlying mechanism of how these pathways
influence non-viral gene transfer have not been studied. Transgene expression is increased on fibronectin (Fn) coated
surfaces as a consequence of increased proliferation, cell spreading and active engagement of clathrin endocytosis
pathway. RhoGTPases mediate the crosstalk between the cell and Fn, and regulate cellular processes involving filamentous
actin, in-response to cellular interaction with Fn. Here the role of RhoGTPases specifically Rho, Rac and Cdc42 in modulation
of non-viral gene transfer in mouse mesenchymal stem (mMSCs) plated in a fibronectin microenvironment was studied.
More than 90% decrease in transgene expression was observed after inactivation of RhoGTPases using difficile toxin B
(TcdB) and C3 transferase. Expression of dominant negative RhoA (RhoAT19N), Rac1(Rac1T17N) and Cdc42 (Cdc42T17N) also
significantly reduced polyplex uptake and transgene expression. Interactions of cells with Fn lead to activation of
RhoGTPases. However, further activation of RhoA, Rac1 and Cdc42 by expression of constitutively active genes (RhoAQ63L,
Rac1Q61L and Cdc42Q61L) did not further enhance transgene expression in mMSCs, when plated on Fn. In contrast,
activation of RhoA, Rac1 and Cdc42 by expression of constitutively active genes for cells plated on collagen I, which by itself
did not increase RhoGTPase activation, resulted in enhanced transgene expression. Our study shows that RhoGTPases
regulate internalization and effective intracellular processing of polyplexes that results in efficient gene transfer.
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Introduction
Although gene delivery can be a robust approach to treat
disease and augment tissue formation, limitations with effective
and save delivery have limited its success as a therapy. Gene
delivery to mammalian cells can be achieved using viral as well as
non-viral delivery systems [1]. Non-viral gene delivery systems
have the advantage of being less immunogenic compared to viral
gene delivery systems as well as allow for large-scale production
and modularity. However, they are limited by their efficacy.
Previous studies have focused on engineering more efficient
delivery vehicles that can overcome one or more of the barriers to
efficient gene transfer [2,3]. Although less common, recent studies
have looked at the cellular microenvironment and the cell itself to
elucidate other approaches to enhance non-viral gene transfer [4–
8]. For example, the stiffness of the matrix where the cells are
plated modulates non-viral gene delivery with cells plated on stiff
surfaces (110 KPa) resulting in enhanced gene transfer due to
increased cell proliferation and survival [8]. Collagen I and IV
have been shown to enhance gene transfer in PC12 cells, which
was correlated with the relative projected nuclear area of the
plated cells [9], while fibronectin and collagen I have been shown
to enhance gene expression in NIH/3T3 cells which has been
correlated to the relative increased internalization on these
surfaces and the pathway of internalization [11]. Cationic lipid-
mediated gene transfer to rat smooth muscle cells is enhanced
when the cells are plated on surfaces that promote avß3 binding,
with antibodies against avß3 and ß3 decreasing the amount of gene
transfer [9]. Further, our laboratory has shown that cellular
microenvironment modulates non-viral gene delivery to mouse
mesenchymal stem cells (mMSCs), specifically we screened 6
different ECM proteins and their combinations for their ability to
enhance gene transfer to mouse mesenchymal stem cells (mMSCs)
using poly(ethylene imine) polyplexes. We found that proteins that
promoted well spread cells (e.g. fibronectin and collagen IV)
resulted in polyplexes being trafficked to the nucleus and enhanced
gene transfer, while those that resulted in less spread cells (e.g.
collagen I) resulted in polyplexes that did not colocalize with the
nucleus and inhibited gene transfer [10]. When comparing the
internalization pathway of polyplexes for cells seeded on
fibronectin or collagen I, we found that different endocytic
pathways are used, with clathrin-mediated endocytosis being the
primary pathway used for cells plated on fibronectin [6]. Further,
polymerized actin, actin-myosin interactions, and the microtubu-
lar network were found to influence non-viral gene transfer to
different extends for cells seeded on fibronectin versus collagen I
[6].
Structural components of the ECM such as Fn are able to
actively mediate crosstalk between the ECM and RhoGTPases by
associating with cell surface receptors, namely integrins [11] and
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syndecans [12], which effectively engage RhoGTPases leading to
adhesion signaling [13,14]. Rho proteins alternate between an
active GTP-bound state and an inactive GDP-bound state. In the
active conformation, GTPases interact with and stimulate the
activity of effectors which participate in signaling cascades that
coordinate various cellular processes such as migration, prolifer-
ation [15], gene expression [16] and cytoskeletal organization.
Studies have shown that Cdc42 mediates cell polarity and
filipodia, Rac mediates protrusion of lamellipodia, and Rho
maintains cell adhesion during migration [17]. Furthermore,
bacterial internalization [18,19], adenovirus internalization [20]
and recently receptor mediated internalization of transferrin [21]
has been shown to be a resultant of host cell actin cytoskeleton
manipulation at level of RhoGTPases. However, the role of
RhoGTPases in non-viral gene transfer has not been previously
investigated. It is likely that the interplay between Fn and integrins
is communicated via the RhoGTPases [22] and the resultant
signaling cascades affecting cytoskeletal dynamics, endocytosis,
gene transcription and proliferation are regulating non-viral gene
transfer in cells plated on Fn. Herein, to begin to understand the
cellular molecules involved in modulating gene delivery to mMSCs
plated on Fn coated surfaces, the role of Rho, Rac and Cdc42
RhoGTPases in the uptake and transgene expression of DNA/PEI
polyplexes was studied. The RhoGTPases were specifically
inhibited using chemical inhibitors and dominant negative gene
products, as well as activated to determine their role in gene
transfer and DNA/PEI internalization.
Results
Fibronectin exposure activates RhoGTPases in mMSCs
The activation of RhoGTPases in mMSCs by fibronectin was
assed using fluorescence immunohistochemistry and molecular
assays. Fluorescence immunohistochemistry of the actin cytoskel-
eton revealed that cells plated on fibronectin-coated surfaces
resulted in an increase in stress fibers compared to cells plated on
tissue culture plastic (Fig. 1A, B, p,0.05), indicative of active
RhoGTPases. The level of RhoGTPase activation was determined
using GLISA assays for RhoA, Rac1,2,3 and Cdc42. To ensure
that the observed activation was due to the interaction of the cell
with the fibronectin coated surface and not the dynamics of cell
spreading, cells were allowed to attach and spread on amine
functionalized PDMS sheets. Following cell spreading, the cell
sheet was flipped on top of fibronectin coated or uncoated tissue
culture plastic and incubated for 20 minutes or 1-hour. At
20 minutes of exposure to fibronectin-coated surfaces, RhoA was
significantly activated (p,0.05), while Cdc42 was not activated
and Rac1,2,3 was inhibited compared to exposure to bare tissue
culture plastic (Fig. 1C). After 1-hour exposure to fibronectin-
coated surfaces, Rac1,2,3 and Cdc42 were significantly activated
(p,0.05), while RhoA was not activated (Fig. 1D).
Inactivation of RhoGTPases for cells plated on fibronectin
inhibits transgene expression
Inactivation of RhoGTPases was used to screen their potential
involvement in mediating non-viral gene transfer in mMSCs.
Inactivation of RhoGTPase using difficile toxin B was character-
ized using actin staining and GLISAs for RhoGTPases. Cells with
inactivated RhoGTPases resulted in less spread cells with a
significant decrease in stress fibers (p,0.01, Fig. 2A, B) and
amount active RhoA, Rac1,2,3 and Cdc42 (p at least,0.05,
Fig. 2C). Cell viability was not significantly affected immediately
after treatment with TcdB and 48 hrs post transfection (Fig. S1A).
RhoA,B,C were selectively inactivated using C3 transferase and
resulted in a significant decrease in actin stress fibers (p,0.01,
Fig. 2A, B) and a significant decrease in active RhoA (p,0.01,
Fig. 2D). Cell viability was maintained at .60% immediately post
C3 transferase treatment as well as 48 hours after treatment and
transfection (Fig. S1B).
Cells were transfected immediately following the inhibitory
treatments and transgene expression was analyzed using a
luciferase assay at 48 hours and the extent of polyplex internal-
ization was assessed using flow cytometry analysis (FACS) after 2-
hours. More than 90% decrease in transgene expression of cells
plated on fibronectin-coated surfaces was observed after treatment
with TcdB and C3 transferase (p,0.001, Fig. 2E). However,
internalization of the complexes was significantly increased
following treatment (p at least,0.05, Fig. 2F).
To further understand the individual role of RhoGTPases,
mMSCs were transiently transfected with GFP fused plasmid
constructs of dominant negative mutants of either RhoA (RhoA-
T19N), or Rac1 (Rac1-T17N) or Cdc42 (Cdc42-T17N) [19,23].
At least 80% cell viability was maintained in cells expressing EGFP
control plasmid and dominant negative genes 16-hours post
plating cells on fibronectin (at time of bolus transfection) and
48 hrs post gene delivery (Fig. S2C). Expression of RhoA-T19N
by cells plated on fibronectin coated surface resulted in a
significant decrease (p,0.01) in stress fibers; however, no
significant difference in stress fibers was observed in cells
expressing dominant negative mutants of Rac1 and Cdc42
(Fig. 3A, B). GLISA analysis of active Rho, Rac1,2,3 and Cdc42
showed a significant decrease in active RhoA upon transfection
with RhoA-T19N (p,0.05), but no change in active Rac or Cdc42
upon transfection with Rac1-T17N or Cdc42-T17N compared to
cells transfected with EGFP (Fig. 3C).
Transgene expression was significantly reduced in the cells
expressing dominant negative form of RhoA, Rac1 and Cdc42
(p,0.05, Fig. 3D). The effect of dominant negative mutants on
internalization was studied by analyzing the uptake of YOYO-3
labeled complexes in GFP positive cells only. A significant
decrease in internalization was observed for cells expressing
dominant negative form of RhoGTPases (p,0.01, Fig. 3E).
Activation of RhoGTPases for cells plated on fibronectin
does not influence transgene expression
Since RhoGTPase inactivation lead to a significant decrease in
gene transfer efficiency for cells plated on fibronectin-coated
surfaces, next we wanted to determine if further activation of
RhoGTPases enhanced transgene expression. Calpeptin (CP) was
used to activate RhoA [24,25]. Treatment with CP did not
significantly change the number of stress fibers in the cell (Fig. 4 A,
B), but did significantly increased the amount of active Rho (by
2.5-fold) (p,0.01, Fig. 4C) compared to cells seeded on fibronectin
coated surfaces that did not receive treatment. Viability was
maintained at 90% or greater compared to cells not treated with
CP immediately after treatment as well as 48 hours post treatment
and addition of polyplexes (Fig. S1C). Epidermal growth factor
(EGF) is an efficient activator of Rac1,2, and Cdc42 [26].
Treatment with EGF resulted in a significant increase in active
Rac1,2,3 and Cdc42 (p,0.01 and ,0.01, Fig. 4C) compared to
cells seeded on fibronectin-coated surfaces that did not receive
treatment. No significant change in cell viability was observed
immediately post treatment and 48 hours post treatment and
transfection (Fig. S1D). No significant difference in transgene
expression (Fig. 4E) and internalization (Fig. 4F) was observed
using treatment with CP or EGF for cells placed on fibronectin.
To confirm the CP and EGF findings, mMSCs were transiently
transfected with GFP fused plasmid constructs of constitutive
RhoGTPases and Non-Viral Gene Delivery
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active mutants of either RhoA (RhoA-Q63L), or Rac1 (Rac1-
Q61L) or Cdc42 (Cdc42-Q61L) [23]. At least 80% cell viability
was maintained in cells expressing EGFP control plasmid and
active genes 16 hours post plating cells on fibronectin (at time of
bolus transfection) and 48 hours post gene delivery (Fig. S2D).
Transfection with constitutively active RhoA mutant resulted in an
increase in stress fiber formation (Fig. 5A, B). Further, a significant
increase in the amount of active RhoA, Rac1 and Cdc42 was
observed for cells transfected with the constitutively active genes (p
at least,0.05, Fig. 5D). Similar to the results obtained for CP and
EGF further activation of RhoGTPases did not enhance transgene
expression further over that observed for cells seeded on
fibronectin and transfected with EGFP (Fig. 5D). Expression of
constitutively active form of RhoA, Rac1 and Cdc42 did not affect
internalization (Fig. 5E). These results confirm that further
activation of RhoA, Rac1 or Cdc42 over what fibronectin
achieves on its own (Fig. 1 C, D) does not alter transgene
expression.
Activation of RhoGTPases for cells plated on collagen I
enhances transgene expression
Activation of RhoGTPases for cells plated on collagen I was
significantly lower compared to cells plated on fibronectin (Fig. 6
vs. Fig. 1). Thus, we used transfection experiments on collagen I to
further test our hypothesis of the importance of active RhoGT-
Pases on non-viral gene transfer. Rho was enhanced 4-fold on
fibronectin coated surfaces but only 1.5-fold for cells plated on
collagen I. Rac was enhanced 1.5-fold for cells plated on
fibronectin but inhibited by 50% for cells plated on collagen I.
Cdc42 was enhanced by 2-fold for cells plated on fibronectin, but
inhibited by 50% for cells seeded on collagen I (Fig. 6A). Cells
were transfected with constitutively active RhoA, Rac1 and Cdc42
and replated on collagen I coated surfaces for 16 hours before
transfection. Rac1 and Cdc42 activation were able to enhance the
transgene expression by 4.1 and 6.7 fold compared to EGFP mock
transfected cells respectively, while RhoA activation had no
difference (Fig. 6B). Since RhoA was activated by cell exposure to
collagen I (Fig. 6A), this result shows that further activation of
RhoA is not beneficial to achieve higher transgene expression
similarly to what was observed for cells plated on fibronectin.
Rho effector protein Rho-Kinase (ROCK) and PKC
mediated phosphorylation modulate gene transfer
ROCK was inhibited using Y27632 (Y2) and PKC was
inhibited using staurosporine (ST). Treatment with Y27632
reduced the number of actin stress fibers while treatment with
Figure 1. RhoGTPase activation on fibronectin. (A) mMSCs were plated on uncoated or fibronectin (40 mg/mL) coated surfaces for 16 hours
and cell morphology was studied by staining cells for actin using Alexa488 conjugated phalloidin (green), and for DNA using Hoechst 33258 dye
(blue). Images were taken with a Zeiss AxioObserver Z1 inverted microscope at 1006magnification. (B) Stress fiber quantification. (C and D) Active
RhoGTPase quantification was performed using GLISA specific for RhoA, Rac1,2,3 and Cdc42. Cells were culture in PDMS sheets and allowed to attach
and spread before exposing them to protein modified plastic for 20 minutes or 1 hour. The average of three samples was plotted. The level of active
RhoGTPase in samples exposed to fibronectin was compared with untreated sample using the unpaired t-test (two tail p value). The symbols *
represents a significant change to the level of p,0.05. The error bars represent the standard deviation in all plots.
doi:10.1371/journal.pone.0035046.g001
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staurosporine lead to a loss of cystoskeletal integrity (Fig. 7A). No
significant change in cell viability was observed immediately after
inhibitor treatment. However, 48 hours post treatment and
transfection, ST significantly reduced (p,0.05) cell viability while
Y2 did not affect the cell viability (Fig. S1E). Y27632 is a specific
inhibitor of ROCK. Treatment with Y27632 resulted in a
significant decrease in overall transgene expression and polyplex
internalization (p,0.01, Figs. 7B and C), further suggesting the
importance of Rho in non-viral gene transfer. PKC inhibition
resulted in a severe decrease in transgene expression and polyplex
uptake (P,0.01).
Discussion
The process of non-viral gene delivery involves various steps,
including cellular internalization, trafficking along the endo-
lysolytic path, endosomal escape, unpackaging, nuclear entry
and gene expression [27]. Modulation of any of these steps can
influence the final transgene expression. While recent studies show
that cellular microenvironment regulates gene delivery [4,7], the
mechanisms activated upon ECM binding that influence effective
gene transfer have not been elucidated. Previously we found that
mMSCs plated on fibronectin coated surfaces resulted in
enhanced gene transfer, while cells plated on collagen I resulted
Figure 2. RhoGTPase inhibition using TcdB and C3 transferase decreases transgene expression. mMSCs were plated on fibronectin
(40 mg/mL) coated tissue culture plastic for 16 hours prior to being treated with 0–300 ng/ml TcdB for 4 hours in serum free media, or 0–1 mg/ml C3
transferase for 4 hours. (A) Cell morphology was studied immediately after treatment with inhibitor, by staining cells for actin using Alexa488 (green)
conjugated phalloidin, and for DNA using Hoechst 33258 dye (blue). Images were taken with a Zeiss AxioObserver Z1 inverted microscope at 1006
magnification. (B) Stress fiber quantification. Statistical analysis was done using a one-way Anova followed by the Dunnett Multiple Comparison test.
The Anova p value was 0.0052. The symbol ** represents a significant change in stress fibers with respect to untreated cells to the level of p,0.01. (C)
Active RhoGTPase quantification was performed using GLISA specific for RhoA, Rac1,2,3 and Cdc42. (D) Active RhoA quantification was performed
using GLISA specific for RhoA. Statistical analysis was done using the unpaired t-test (two tail p value) where active RhoGTPase level in treated cells
was compared with untreated cells. The symbols * and ** represents a significant change to the level of p,0.05 and p,0.01, respectively. (E) Cells
were transfected immediately post treatment and transgene expression was analyzed at 48 hours using luciferase assay and normalized with total
protein quantified using Peirce BCA assay. (F) Cells were transfected immediately post treatment with YOYO-1 labeled polyplexes and after 2 hours
cells were collected with trypsin and polyplex internalization analyzed by flow cytometry. A total of 7000 events were analyzed per sample.
Experiments were performed in triplicate and the average plotted with the error bars representing the standard deviation. Fold increase in transgene
expression and internalization was calculated with respect to the untreated control. Statistical analysis for gene transfer and internalization was done
using a one-way Anova followed by the Tukey-Kramer Multiple Comparison test, which compares all columns. The Anova p values for transgene
expression were 0.004 and 0.0052 for TcdB and C3 transferase, respectively and the Anova p values for internalization were ,0.0001 and 0.0067 for
TcdB and C3 transferase, respectively. The symbol ***, ** and * represents a significant change in gene expression or internalization with respect to
sample not treated with inhibitor to the level of p,0.001, p,0.01 and p,0.05, respectively.
doi:10.1371/journal.pone.0035046.g002
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in inhibited gene transfer compared to cells seeded on uncoated
surfaces [6]. Here we aimed to determine if RhoGTPase
activation was one of the reasons for the observed enhancement
in transgene expression for cells plated on fibronectin-coated
surfaces.
RhoGTPases have been primarily implicated as the controlling
factors in guiding cell motility, morphology, contractility and
proliferation [17]. RhoGTPases have also been implicated in
regulating phagocytosis [28], endocytic trafficking [29], as well as
mediating the various steps of vesicular trafficking [30]. Thus,
RhoGTPases can play a role in polyplex uptake and polyplex
intracellular trafficking. Fibronectin has been previously shown to
enhance signaling through RhoGTPases [11,14,31,32]. Initial
activation of Rac and Cdc42 by fibronectin has been shown to
Figure 3. RhoGTPase inhibition using dominat negative gene
products decreases transgene expression. mMSCs were transient-
ly transfected with dominant negative forms of RhoA, Rac1 or Cdc42
with a plasmid also containing EGFP. 24 hours post transfection, cells
were replated on fibronectin coated plates and cultured for 16 hours
prior to bolus transfection. Cells transfected with pEGFP were used as
control. (A) Alexa488 conjugated phalloidin (green), and Hoechst dye
(blue) staining. Images were taken with a Zeiss AxioObserver Z1
inverted microscope at 1006magnification. (B) Stress fiber quantifica-
tion. Statistical analysis was done using a one-way Anova followed by
the Dunnett Multiple Comparison test. The Anova p value was 0.0015.
The symbol * represents a significant change in stress fibers with
respect to untreated cells to the level of p,0.05. (C) Active Rho, Rac
and Cdc42, was assessed for cells replated on fibronectin for 16 hours
using GLISA assays specific for RhoA, Rac1,2,3 and Cdc42. Statistical
analysis was done using the unpaired t-test (two tail p value). The
symbol * represents a significant change to the level of p,0.05. (D) The
transgene expression was analyzed 48 hours post transfection using
luciferase assay and normalized with total protein analyzed using Peirce
BCA assay. (E) Internalization was analyzed using YOYO-3 labeled
polyplexes 2 hours post transfection using flow cytometry. A total of
10,000 events were analyzed per sample and the mean fluorescence of
events positive for both GFP and YOYO-3 was analyzed. Statistical
analysis for gene transfer and internalization was done using a one-way
Anova followed by the Dunnett Multiple Comparison test. The Anova p
values were 0.0219 and ,0.0001 for transfection (D) and internalization
(E) respectively. The symbols * and ** represents a significant change
with respect to cells transfected with control plasmid (pEGFP) to the
level of p,0.05 and p,0.01, respectively.
doi:10.1371/journal.pone.0035046.g003
Figure 4. Effect of RhoGTPase activation using calpeptin (CP)
and epidermal growth factor (EGF) on gene transfer. mMSCs
cells were cultured for 8 hours on fibronectin wells, followed by
overnight serum starvation and then treated with 0–100 mg/ml CP for
10 minutes or 0–100 ng/ml EGF for 2 minutes in serum free media. (A)
After treatment, the changes in cell morphology were visualized
through lexa488 conjugated phalloidin (green) and for DNA using
Hoechst 33258 dye (blue) staining. Images were taken with a Zeiss
AxioObserver Z1 inverted microscope at 1006magnification. (B) Stress
fiber quantification. (C) Active RhoGTPase quantification after treatment
was performed using GLISA specific for RhoA, Rac1,2,3 and Cdc42. (D)
Transfection was performed immediately post treatment in serum free
media. 4 hours post transfection media was replaced with complete
media. The transgene expression was analyzed 48 hours post
transfection using luciferase assay and normalized with total protein
analyzed using Peirce BCA assay. (E) Internalization was analyzed
2 hours post transfection using flow cytometry of YOYO-1 labeled
polyplexes. A total of 7000 events were analyzed per sample. Statistical
analysis for the level of active RhoGTPase, transgene expression and
internalization, was done using the unpaired t-test (two tail p value)
where treated sample was compared with untreated sample. The
symbols ** and *** represents a significant change to the level of
p,0.01 and p,0.001, respectively.
doi:10.1371/journal.pone.0035046.g004
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mediate cell spreading in NIH/3T3 cells [14,32]. Our results show
that exposure of mMSCs to fibronectin coated surfaces results in
enhanced activation of the RhoGTPases namely RhoA, Rac1,2,2
and Cdc42, in mMSCs. To study the role of RhoGTPases on non-
viral gene transfer for mMSCs plated on fibronectin coated
surfaces, systematic inhibition and activation by molecular
inhibitors as well as dominant negative or positive genes were
used.
RhoGTPases were inhibited using bacterial toxins (TcdB and
C3 transferase) and dominant negative genes. TcdB irreversibly
inactivates Rho, Rac and Cdc42 by glycosylation of the threonine
residue [33,34], while C3 selectively inhibits RhoA, B and C [35],
but not Rac or Cdc42, by modifying the aspargine41 at the
effector region of the GTPase. Inhibition by bacterial toxins
resulted in a significant decrease (at least p,0.05) in the overall
amount of active Rho, Rac and Cdc42. Further, a significant
decrease (p,0.05) was observed in active RhoA upon transfection
with RhoAT19N but no change was observed in active Rac or
Cdc42 upon transfection with Rac1T17N and Cdc42T17N,
respectively. Since for both inhibition protocols cells are seeded
on fibronectin, these results indicate that the dominant negative
gene could inhibit RhoA even though the cells are plated on
fibronectin, but the dominant negative gene could only reduce the
activation of Rac and Cdc42 to background levels when the cells
are plated on fibronectin.
Consistent with our hypothesis of the involvement of RhoGT-
Pases on non-viral gene transfer, inhibition of RhoGTPases led to
a significant decrease in transgene expression. Although the exact
mechanism of how RhoGTPases influence successful non-viral
gene transfer cannot be determined from our data, we predict that
the regulation of actin-microtubule dynamics, cell proliferation
[15] and gene transcription via integrin-dependent intracellular
signaling pathways [16] positively influence non-viral gene
transfer. RhoGTPases have been implicated in endocytosis of
bacteria and viruses by mammalian cells. For example, Rac1,
RhoA, and Cdc42 are required for HeLa cell invasion by group B
streptococcus [19], RhoA positively regulates the pathway by
which Madin-Darby canine kidney (MDCK) cells internalize P.
aeruginosa strain PA103 [18], and Rho C enhances macropino-
cytosis and modulates entry of Ebola virus and vesicular stomatitis
virus pseudotyped vectors.
Interestingly the effect on polyplex internalization was not the
same for the bacterial toxins and transfection with dominant
negative genes. While inhibition of RhoGTPases using TcdB and
C3 transferase led to an increase in polyplex internalization,
inhibition with dominant negative genes led to a decrease in
internalization. We cannot offer a definitive reason for these
findings. The observed increase in internalization on treatment
with TcdB could be due to TcdB mediated activation of
phospholipase C and D [34], leading to regulation of receptor
mediated endocytosis [36,37]. The increase observed on C3
treatment correlates with our previous study where depolymer-
ization of actin using cytochalasin D enhanced polyplex uptake in
mMSCs cultured on fibronectin [6]. The observed decrease in
internalization for inhibition with dominant negative genes could
possibly be due to inhibition of macropinocytosis by dominant
negative mutants of Cdc42 and Rac1, as was shown for bone
marrow derived dendritic cells [38].
Since we found that exposure of mMSCs to fibronectin activates
RhoGTPases (1.5- to 4-fold) and enhances transgene expression,
we wanted to determine if further activation of RhoGTPases could
further enhance transgene expression. RhoGTPases were activat-
ed using calpeptin, EGF and transfection with constitutively active
RhoGTPase mutants. Calpeptin (CP) is a cell permeable calpain
inhibitor known to activate Rho leading to stress fiber formation
[24,25]. Treatment with calpeptin and EGF did not influence the
transgene expression or polyplex uptake. Although we show that
Figure 5. Effect of expression of constitutively active mutants
of RhoGTPases on gene transfer. mMSCs plated on a 6-well plate
were transiently transfected with constitutive active forms of RhoA,
Rac1 or Cdc42 conjugated with GFP, using lipofectamineTM2000. Cells
transfected with pEGFP were used as control. After 24 hours, cells were
harvested and replated on fibronectin-coated surfaces. (A) 24 hours
post transfection with constitutive active forms of RhoGTPases in cells
plated on tissue culture plastic, changes in cell morphology were
analyzed through actin and DNA staining using Alexa488 conjugated
phalloidin (green), and Hoechst 33258 dye (blue), respectively. (B) The
number of stress fibers per cell were counted. (C) Active Rho, Rac and
Cdc42-GTPases were assessed using GLISA assays 24 hours post
transfection with constitutive active forms of RhoGTPases and
overnight serum starvation. (D) The replated cells were cultured for
16 hours on fibronectin before bolus transfection. The transgene
expression was analyzed 48 hours post transfection using luciferase
assay and normalized with total protein analyzed using Peirce BCA
assay. (E) Internalization was analyzed 2 hours post transfection using
flow cytometry and YOYO-3 labeled polyplexes. A total of 10,000 events
were analyzed per sample and the mean fluorescence of events positive
for both GFP and YOYO-3 was analyzed. Statistical analysis for number
of stress fibers, ruffles, transgene expression and internalization was
done using the Dunnett multiple comparison test.
doi:10.1371/journal.pone.0035046.g005
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EGF activates Rac and Cdc42, EGF also stimulates macropino-
cytosis [39]. Therefore, the role of activated RhoA, Rac1 and
Cdc42 was specifically studied by transiently expressing constitu-
tively active RhoGTPase mutants. Transfection with constitutively
active RhoGTPases resulted in increased amounts of active RhoA,
Rac and Cdc42. However, like CP and EGF treatment, the
expression of constitutively active RhoA, Rac1 and Cdc42 did not
influence transgene expression or uptake for mMSCs plated on
fibronectin. These results indicate that a further activation of
RhoGTPases does not increase transgene expression in mMSCs
cultured on fibronectin-coated dishes.
As mentioned we previously observed that gene transfer to
mMSCs plated on collagen I was inhibited [6]. Thus, we
investigated if the activation of RhoGTPases could rescue the
transfection ability of mMSCs plated on collagen I. For mMSCs
exposed to collagen I coated dishes, only Rho was slightly
activated, while both Rac and cdc42 were inhibited. The
activation of Rac1 and Cdc42 with constitutively active genes
increased the transgene expression by 4.1 and 6.7 fold,
respectively, for cells plated on collagen I coated surfaces. As
was the case for cells seeded on fibronectin, the further activation
of RhoA by transfection with a constitutively active RhoA gene
does not further stimulate gene transfer. On the other hand, Rac
and Cdc42 were inhibited on Collagen I coated surfaces, and thus
the fact that transfection with constitutively active Cdc42 and
Rac1 increased transgene expression indicates that these RhoGT-
Pases can promote transgene expression in cells with less active
RhoGTPases.
The small RhoGTPases employ downstream effectors to
mediate their effects on cell morphology, focal adhesion and
migration. RhoGTPase binds to serine/threonine kinases [40]
namely Rho Kinase, ROK and the related p160ROCK; and
elevate their activity. The role of Rho downstream effector ROCK
in non-viral gene transfer was also investigated. ROCK inhibition
using Y27632 significantly decreased the polyplex internalization
and transgene expression. This suggests that cell contractility
mediated by ROCK contributes to the regulation of polyplex
uptake by RhoGTPase. Besides ROCK, there are other Rho
effector molecules like Phosphatidyl inositol 4-phosphate 5-kinase
(PIP5-kinase) and p140mDia that also regulate actin polymeriza-
tion [41,42] and could play a role in mediating gene transfer and
would be interesting to study in future.
Besides integrins, syndecans also mediate cell-Fn interactions
[43] and activate PKC, which acts upstream to activate
RhoGTPases [44] and mediate cell contractility. Syndecan-4
directly recruits PKC-a and facilitates focal adhesion formation on
fibronectin [45]. To determine the function of PKC in non-viral
gene transfer, it was inhibited using staurosporine. A decrease in
transgene expression was seen on PKC inhibition as a resultant of
decreased internalization and proliferation. PKC stimulation has
been shown to induce clathrin mediated endocytosis of a5b1 [46]
and actin dependent uptake of cationic DNA complexes [47].
These results indicate RhoGTPase activity regulated by PKC [44]
is required for effective transgene expression.
In conclusion, our results indicate that RhoGTPases modulate
non-viral gene transfer for mMSCs plated on fibronectin-coated
surfaces. Our results show that the engagement of the ECM
dictates the RhoGTPase activation level, which in turn dictates the
efficiency of transgene expression. Activation of RhoGTPases for
cells with inactive RhoGTPases leads to enhanced transgene
expression, but activation of RhoGTPases for cells with already
active RhoGTPases does not result in further enhancement. Since
only RhoA, Rac1 and Cdc42 were studied we cannot offer
conclusions about the involvement of RhoGTPases (e.g. RhoB/
C)nin non-viral gene transfer. We believe that a molecular
understanding of the process of non-viral gene transfer is necessary
to engineer systems that achieve efficient gene delivery.
Materials and Methods
Cell Culture
Mouse bone marrow cloned mesenchymal stem (D1,
CRL12424) were purchased from ATCC (Manassas, VA, USA).
Cells were maintained in Dulbecco’s modified eagle’s medium
Figure 6. Effect of expression of constitutively active mutants of RhoGTPases on gene transfer for cells cultured on collagen I
substrates. (A) mMSCs were cultured on amine functionalized PDMS strips and serum starved overnight before exposing to collagen I coated
surfaces for 20 minutes to assess Rho-GTP and 1 hour to assess Rac and Cdc42-GTPases. The cells were subsequently lysed and respective GLISA
assays were performed to quantify RhoA, Rac1,2,3 and Cdc42. Statistical analysis was done using the unpaired t-test (two tail p value). (B) mMSCs
transiently transfected with constitutively active negative of RhoA, Rac1 or Cdc42 conjugated with GFP were cultured on collagen I coated plates for
16 hours prior to bolus transfection with polyplexes. The transgene expression was analyzed 48 hours post transfection using luciferase assay and
normalized with total protein analyzed using Peirce BCA assay. Statistical analysis was done using a one-way Anova followed by the Dunnett Multiple
Comparison test. The Anova p value was 0.0203. The symbols *, ** and *** represents a significant change to the level of p,0.05, p,0.01 and
p,0.001, respectively.
doi:10.1371/journal.pone.0035046.g006
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(Sigma-Aldrich, St. Louis, MO) containing 10% bovine growth
serum (BGS, Hyclone, Logan, Utah) and 1% penicillin/strepto-
mycin antibiotics (Invitrogen, Grand Island, NY) and cultured at
37uC and 5% CO2.
Protein coating
Stock solution fibronectin (1 mg/ml, Millipore, Billerica, MA)
was diluted to 40 mg/ml in phosphate buffered saline (PBS), and
added in each well of a tissue culture plate. The plate was
incubated over night at 4uC in a humid environment, followed by
incubation at 37uC for 2 hours [48]. The solution was removed
and wells were washed twice with PBS to remove unbound
proteins. Wells were further incubated with BSA (1% in PBS) for
30 minutes at 37uC followed by two washings with PBS.
Analysis of RhoGTPase activation by fibronectin or
collagen I
Poly-dimethoxy silane (PDMS) sheets were made by mixing
Sylgard 184 PDMS prepolymer thoroughly in a 10:1 mass ratio of
silicone elastomer to curing agent, degassing and casting in a
square dish at 60uC overnight. After the cured PDMS sheets were
removed, they were cut into strips and oxygen plasma treated
using Technics RIE (Reactive Ion Etching) for 3 minutes at
100 mTorr of O2, 100 W or 15 minutes at 200 mTorr of O2,
200 W. The PDMS strips were subsequently placed in a 1:1 v/v
methanol and hydrochloric acid solution for 30 minutes, then
dried and incubated overnight in a 5% v/v amino-propyl
triethoxysilane (APTES, Sigma-Aldrich, St. Louis, MO) solution
in ethanol, at room temperature and in inert atmosphere [49].
The sheets were sterilized in 70% ethanol prior to cell plating. The
cells were cultured for a day till confluent and then serum starved
overnight before exposing them to fibronectin or collagen I coated
surfaces. Five minutes before exposing cells to fibronectin or
collagen I, sodium orthovanadate (0.1 mM) was added to the cell
culture media. Sodium orthovanadate is an inhibitor of protein
tyrosine phosphatases and alkaline phosphatases and was used to
preserve the phosphorylation of RhoGTPases through inhibiting
endogenous phosphatases [14].
The PDMS cell sheets were exposed to fibronectin or collagen I
for 20 min or 1 hour, which have been shown to be the duration
of RhoGTPase activation in different cells after interaction with
the extracellular matrix [11,14,31,32]. After exposure to ECM
protein at 37uC, the strips were placed in Petri dishes on ice and
rinsed once with ice cold PBS supplemented with 0.2 mM sodium
orthovanadate. The lysis buffer provided with the GLISA kit
(Cytoskeleton, Inc., Denver, CO) was modified to include 5 mM
sodium orthovanadate, 50 mM sodium fluoride and 0.5 mM
phenylmethylsulfonyl fluoride (PMSF), along with 16 protease
inhibitor cocktail provided with Kit [14,50] After aspirating all
liquid from the PDMS strips, 100 ul of lysis buffer was added and
scraped. Cell lysate was immediately clarified by centrifugation at
9,000 rcf, 4uC for 2 minutes, aliquoted into microcentrifuge tubes
and snap frozen in liquid nitrogen, as indicated by the
manufacture’s protocol. After 1 or 2 days, the frozen aliquots
were analyzed and RhoGTPases activity assessed, as per
manufacture’s protocol.
Chemical inhibition of RhoGTPases
Difficile toxin B (TcdB, List Biologicals, Campbell, CA) was
used to pharmacologically inhibit Rho, Rac and Cdc42 [18–
20,28,51]. Rho was specifically inhibited using cell permeable C3
transferase (C3, Cytoskeleton, Denver, CO) [18,28,51]. mMSCs
were seeded on fibronectin coated 48-well plates or 24-well plates
at cell densities of 20,000 and 50,000 cells/well respectively. The
cells were allowed to attach for 14–15 hours before the media in
the wells was replaced with serum free media containing 0–1 mg/
ml C3 transferase (C3) or 0–300 ng/ml TcdB for 4 hours.
Immediately post treatment, media was changed with serum
containing media and DNA/PEI internalization and overall
transgene expression studied. To assess RhoGTPase inhibition,
cell morphology was analyzed and respective GLISA assays were
performed, immediately after inhibitor treatment.
Chemical activation of RhoGTPase
Cells were allowed to attach on fibronectin-coated plates for
8 hours followed by overnight incubation in serum free media.
Rho was pharmacologically activated by s incubating cells in
presence 25 mg/ml Calpeptin (CP, Cytoskeleton, Inc., Denver,
CO) for 10 minutes while Rac and CDC42 were activated by
incubating cells in presence of 50 ng/ml Epidermal growth factor
(EGF, Cytoskeleton) for 2 minutes. Immediately after treatment
cell morphology, internalization and gene expression were
analyzed. For analysis of non-viral gene transfer, cells were
transfected with polyplexes in serum free media for 2–4 hrs,
following which media was replaced with serum containing media.
Figure 7. PKC and ROCK inhibition, inhibit gene transfer in
cells plated on fibronectin. mMSCs were cultured for 16 hours on
fibronectin coated plates prior to treatment with 10 mM Y27632 (Y2) or
100 nM Staurosporine (ST) for 2 hours to inhibit ROCK and PKC,
respectively. (A) Changes in mMSC cell morphology were visualized
through staining for actin using Alexa488 conjugated phalloidin and for
DNA using Hoechst 33258 dye. Images were taken with a Zeiss
AxioObserver Z1 inverted microscope at 406 magnification. Immedi-
ately after treatment with inhibitor, the medium was replaced and
bolus transfection was done. (B) Transgene expression was analyzed
48 hours post transfection using luciferase assay and normalized with
total protein analyzed using Peirce BCA assay. Internalization was
assessed 2 hours post transfection using flow cytometry and YOYO-1
labeled polyplexes (C). A total of 7000 events were analyzed per
sample. Statistical analysis was done using a one-way Anova followed
by the Dunnett Multiple Comparison test. The Anova p value was
0.0003 and ,0.0001 for transgene expression and internalization,
respectively. The symbols ** represents a significant change to the level
of p,0.01.
doi:10.1371/journal.pone.0035046.g007
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Activated Rho, Rac and Cdc42 were confirmed by performing
respective activation G-LISA assays (RhoA, Rac1,2,3 and Cdc42
G-LISA Activation Assays; Cytoskeleton) with lysates from
activated and control samples as per manufacturer’s protocol.
Overnight serum starved cells were treated as the control sample.
To assess activity, samples were subsequently treated with 25 mg/
ml calpeptin for 10 minutes or with 50 ng/ml EGF for 2 minutes.
Activity of RhoA, Rac and Cdc42 respectively was assessed using a
GLISA assay and normalized to values obtained for control
lysates.
Transient inhibition and activation of RhoGTPase
Specific inhibition and activation of the RhoGTPases was done
by a method described by Burnham et al. [19] with minor
modification. Plasmids expressing dominant negative Rac1
(pcDNA3-EGFP-Rac1-T17N), RhoA (pcDNA-EGFP-RhoA-
T19N) and Cdc42 (pcDNA-EGFP-Cdc42-T17N), as well as
plasmids expressing constitutively active mutants of RhoA
(pcDNA-EGFP-RhoA-Q63L), Rac1 (pcDNA-EGFP-RhoA-
Q61L) and Cdc42 (pcDNA-EGFP-Cdc42-Q61L) were kindly
provided by Dr Garry Bokoch (The Scripps Research Institute, La
Jolla, CA) [23,52]. 56104 and 256104 cells were plated per well in
a 24 and 6 well plate respectively, and cultured for 24 hours prior
to transfection. For every 1 mg of DNA, 2 ml of LipofectamineTM
2000 transfection reagent was added to the DNA solution,
vortexed for 15 seconds and incubated at room temperature for
20 minutes. Complexes were added directly to the medium of the
plated cells at a final DNA concentration of 1 mg per well for 24-
well plates and 2.5 mg per well for 6-well plates. Analysis of GFP
expression in transfected cells using FACS showed 30–40% cells to
be successfully transfected with dominant negative or constitutively
active genes and control plasmid (Fig. S2 A, B). 24 hours post
transfection, cells were harvested and used to study the effect of
RhoGTPase inhibition or activation on transgene expression as
well as internalization. Activation or inhibition was analyzed by
assessing RhoGTPases activity using respective GLISA assays
(RhoA, Rac and Cdc42 G-LISA Activation Assays; Cytoskeleton)
as per manufacturer’s protocol. Cells transfected with pEGFP
using LipofectamineTM 2000, were used as control for studies
involving transfection with dominant negative and constitutively
active genes. For assessing activation, 24 hours post transfection
with constitutive active genes, cells were serum starved overnight
and then harvested for performing respective activation G-LISA
assays and studying morphology. For assessing inhibition,
24 hours post transfection with dominant negative genes, cells
were replated on fibronectin coated surface overnight and
harvested for performing GLISA assays and studying morphology.
Transfection
pEGFP-luc plasmid was purchased from clontech (Palo Alto,
CA) and expanded using a Giga Prep Kit from Qiagen following
the manufacturer’s protocol. Linear poly-(ethylene imine) (25 kDa,
PEI) was purchased from Polysciences (Warrington, PA). The cells
were allowed to attach and cultured under various conditions as
per required for the experiments mentioned. For gene transfer
studies, DNA/PEI polyplexes were formed by mixing equal
volumes of plasmid DNA with PEI. For every 1 mg of DNA,
1.65 mg of PEI was added to the DNA solution to get N/P of 12,
vortexed for 15 seconds and incubated at room temperature for
15 minutes. Polyplexes were added directly to the medium of the
plated cells at a final DNA concentration of 0.5 mg for 48-well
plates. Salt was added directly to the wells post addition of
transfection solution to get a final concentration of 150 mM NaCl.
Transfection was quantified at 48 hours post transfection using the
Promega Luciferase Assay System following the manufacturer’s
instructions. Subsequently, the total amount of protein in samples
was analyzed using Peirce BCA assay with or without compat-Able
protein assay preparation kit as per manufacturer’s protocol.
Experiments were carried out in triplicates and results were
expressed as relative light units (RLU) per mg of cell protein.
Internalization of polyplexes
Plasmid DNA (pEGFPluc) and the fluorescent DNA-interca-
lator YOYO-1 or YOYO-3 were mixed at a ratio of 1 dye
molecule per 50 base pairs and allowed to complex for 60 minutes
at room temperature. YOYO-1 or YOYO-3 labeled DNA was
then used to prepare PEI/DNA complexes at a N/P of 12, bolus
transfection was performed and cells were exposed to polyplexes
for 2 hours. For YOYO-1 labeled complexes, cells were washed
with PBS, trysinized with 50 ml of 0.25% trypsin-EDTA and
suspended in 350 ml of 0.04% tryphan blue in 1% BGS in PBS to
quench the flourescence of extracellular associated DNA. For
YOYO-3 labeled complexes, cells were washed twice for
10 minutes with cellscrub to remove extracellular associated
DNA, trysinized and suspended in 1% BGS in PBS. YOYO-1
fluorescent cells having were detected by flow cytometry with a
FACScan X and data was analyzed with CELLQuest (Beckton
Dickinson). YOYO-3 fluorescent cells were detected by flow
cytometry using BD LSR II and data was analyzed with
FACSDiVa (Beckton Dickinson). Experiments were performed
in triplicates analyzing 7000 or 10000 total events per sample.
Microscopy and quantification of stress fibers
D1 cells were plated on fibronectin coated plastic coverslips
prior to culture. Immediately after treatment with Rho protein
activators or inhibitors, cells were fixed with 5% paraformalde-
hyde for 15 minutes and permeabilized with 0.1% tritonX100 in
16 PBS for 3 minutes. The cells were stained for actin using
Alexa488-phalloidin and for DNA using Hoechst 33258 dye. The
staining solution was added in each well and left in dark for 30–
60 minutes at room temperature followed by washings with 0.05%
tween-20. Images were taken with a Zeiss AxioObserver Z1
inverted microscope at 1006magnification. The number of stress
fibers per cell was quantified by counting the individual fibers
observed in 1006 pictures taken of cells in the respective
condition.
Statistical methods
All statistical analyses were performed using the computer
program Instat (GraphPad, San Diego, CA). Experiments were
statistically analyzed using a one-way ANOVA followed by a post-
hoc test if the ANOVA result was p,0.05. Experiments were
statistically analyzed using the Tukey test, which compares all
pairs of columns, using a 95% confidence interval or using the
Dunnet test which compares all columns versus a control column
or using the unpaired t-test (two tail p value), which compares two
different columns. Statistical significance was determined using a
95% confidence interval. Data is plotted as the mean of at least
three independent measurements and standard deviation.
Supporting Information
Figure S1 Effect of inhibitors and activators on cell
viability. To study the effect of RhoGTPase inhibition on gene
transfer, mMSCs were plated on fibronectin (40 mg/mL) coated
tissue culture plastic surfaces for 16 hours prior to being treated
with 0–300 ng/ml TcdB for 4 hours in serum free media, or 0–
1 mg/ml C3 transferase for 4 hours. Cells were transfected
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immediately post treatment with inhibitors. For studying the effect
of RhoGTPase activation, mMSCs were cultured for 8 hours on
fibronectin, followed by overnight serum starvation and then
treated with 0–100 mg/ml CP for 10 minutes or 0–100 ng/ml
EGF for 2 minutes in serum free media. Subsequently, immedi-
ately post treatment with activators, bolus transfection was done
for 4 hours in serum free media. For assessing the role of ROCK
and PKC in gene transfer, mMSCs were cultured for 16 hours on
fibronectin prior to treatment with 10 mM Y27632 (Y2) for
2 hours or 100 nM Staurosporine (ST) for 2 hours to inhibit
ROCK and PKC, respectively. Immediately after treatment with
ST or Y2, the medium was replaced and bolus transfection was
done. Cell proliferation was analyzed immediately after treatment
with TcdB (A), C3 transferase (B), CP (C), EGF (D) and ST or Y2
(E), as well 48 hrs post treatment and transfection by measuring
calcien AM fluorescence after live/dead staining. The cell viability
obtained after specific inhibitor treatment were statistically
compared using Tukey-Kramer Multiple Comparison test, which
compares all pairs with each other. The symbols *, **, and
*** represents a significant change to the level of p,0.05, p,0.01,
and p,0.001 respectively.
(TIF)
Figure S2 Percent cells transfected with dominant
negative and constitutively active genes, and the effect
on cell viability. To study the effect of direct inhibition and
activation of RhoGTPase on gene transfer in cells plated on
fibronectin tissue culture plastic, D1 cells were transiently
transfected using lipofectamineTM2000, with dominant negative
or constitutively active forms of RhoA, Rac1 or Cdc42 conjugated
with GFP. The distribution and percentage of cells transfected
with dominant negative genes (A) or constitutively active genes (B),
was assessed by analyzing GFP expression using flowcytometry.
The cells were subsequently cultured on Fn for 16 hours prior to
bolus transfection using linear polyethyleneimine (LPEI). The cell
viability was determined 16 hours after culturing cells on
fibronectin as well as 48 hours post addition of polyplexes using
live/dead assay, for cells transfected with dominant negative genes
(C) or constitutively active genes (D).
(TIF)
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